Intensive Glycemic Treatment Mitigates Cardiovascular and Mortality Risk Associated With Cardiac Autonomic Neuropathy in Type 2 Diabetes

Intensive Glycemic Treatment Mitigates Cardiovascular and Mortality Risk Associated With Cardiac Autonomic Neuropathy in Type 2 Diabetes

Background Hyperglycemia is one of the proposed risk factors for cardiac autonomic neuropathy (CAN). CAN is associated with increased cardiovascular and mortality risk. But it remains unclear whether cardiovascular and mortality risk associated with CAN is mitigated by intensive glycemic treatment....

Full description

Saved in:
Bibliographic Details
Main Authors: Huimin Zhou, Yiquan Huang, Peihan Xie, Shaozhao Zhang, Menghui Liu, Zhenyu Xiong, Rihua Huang, Xingfeng Xu, Miaohong Li, Ziwei Zhou, Wenjing Zhang, Junqi Zhong, Yue Guo, Jingzhou Jiang, Xinxue Liao, Xiaodong Zhuang
Format: Article
Language:English
Published: Wiley 2025-05-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
cardiac autonomic neuropathy
cardiovascular risk
mortality risk
type 2 diabetes
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.124.035788
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items